Altered Neuronal Markers Following Treatment with Mood Stabilizer and Antipsychotic Drugs Indicate an Increased Likelihood of Neurotransmitter Release

키워드

참고문헌 (56)

1. Pompili M, "Assessment and treatment of suicide risk in bipolar disorders", Expert Rev Neurother, 9, pp.109~136 (2009)
2. Montross LP, "Suicidal ideation and suicide attempts among middle-aged and older patients with schizophrenia spectrum disorders and concurrent subsyndromal depression", J Nerv Ment Dis, 196, pp.884~890 (2008)
3. Newberg AR, "Neurobiology of bipolar disorder", Expert Rev Neurother, 8, pp.93~110 (2008)
4. Dean B, "Changes in the molecular structure of the brain in bipolar disorder: findings using human postmortem brain tissue", World J Biol Psychiatry, 3, pp.125~132 (2002)
5. Scarr E, "Role of the cholinergic system in the pathology and treatment of schizophrenia", Expert Rev Neurother, 9, pp.73~86 (2009)
6. Lewis DA, "Neuroplasticity of neocortical circuits in schizophrenia", Neuropsychopharmacology, 33, pp.141~165 (2008)
7. Geyer MA, "Serotonin research: contributions to understanding psychoses", Trends Pharmacol Sci, 29, pp.445~453 (2008)
8. Laruelle M, "Mechanism of action of antipsychotic drugs: from dopamine D(2) receptor antagonism to glutamate NMDA facilitation", Clin Ther, 27(Suppl A), pp.S16~S24 (2005)
9. Honer WG, "Cingulate cortex synaptic terminal proteins and neural cell adhesion molecule in schizophrenia", Neuroscience, 78, pp.99~110 (1997)
10. Gabriel SM, "Increased concentrations of presynaptic proteins in the cingulate cortex of subjects with schizophrenia", Arch Gen Psychiatry, 54, pp.559~566 (1997)
11. Thompson PM, "Altered levels of the synaptosomal associated protein SNAP-25 in schizophrenia", Biol Psychiatry, 43, pp.239~243 (1998)
12. Fatemi SH, "Altered levels of the synaptosomal associated protein SNAP-25 in hippocampus of subjects with mood disorders and schizophrenia", Neuroreport, 12, pp.3257~3262 (2001)
13. Honer WG, "Abnormalities of SNARE mechanism proteins in anterior frontal cortex in severe mental illness", Cereb Cortex, 12, pp.349~356 (2002)
14. Pennington K, "Proteomic analysis reveals protein changes within layer 2 of the insular cortex in schizophrenia", Proteomics, 8, pp.5097~5107 (2008)
15. Gibbons AS, "Regional and duration of illness differences in the alteration of NCAM-180 mRNA expression within the cortex of subjects with schizophrenia", Schizophr Res, 112, pp.65~71 (2009)
16. Barakauskas VE, "A novel mechanism and treatment target for presynaptic abnormalities in specific striatal regions in schizophrenia", Neuropsychopharmacology, 35, pp.1226~1238 (2010)
17. Beasley CL, "Reductions in cholesterol and synaptic markers in association cortex in mood disorders", Bipolar Disord, 7, pp.449~455 (2005)
18. Scarr E, "Increased levels of SNAP-25 and synaptophysin in the dorsolateral prefrontal cortex in bipolar I disorder", Bipolar Disord, 8, pp.133~143 (2006)
19. Gray LJ, "Region and diagnosis-specific changes in synaptic proteins in schizophrenia and bipolar I disorder", Psychiatry Res, 178, pp.374~380 (2010)
20. 김형욱, "Altered expression of apoptotic factors and synaptic markers in postmortem brain from bipolar disorder patients", NEUROBIOLOGY OF DISEASE, 37, pp.596~603, ACADEMIC PRESS INC ELSEVIER SCIENCE
21. Dean B, "Signal transmission, rather than reception, is the underlying neurochemical abnormality in schizophrenia", Aust N Z J Psychiatry, 34, pp.560~569 (2000)
22. Chen G, "Enhancement of hippocampal neurogenesis by lithium", J Neurochem, 75, pp.1729~1734 (2000)
23. Wang HD, "Effects of antipsychotic drugs on neurogenesis in the forebrain of the adult rat", Neuropsychopharmacology, 29, pp.1230~1238 (2004)
24. Kodama M, "Chronic olanzapine or fluoxetine administration increases cell proliferation in hippocampus and prefrontal cortex of adult rat", Biol Psychiatry, 56, pp.570~550 (2004)
25. Tohen M, "Onset of action of antipsychotics in the treatment of mania", Bipolar Disord, 2, pp.261~268 (2000)
26. Tohen M, "Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy", Arch Gen Psychiatry, 59, pp.62~69 (2002)
27. Citrome L, "Use of mood stabilizers among patients with schizophrenia, 1994-2001", Psychiatr Serv, 53, pp.1212~ (2002)
28. Haw C, "A survey of the off-label use of mood stabilizers in a large psychiatric hospital", J Psychopharmacol, 19, pp.402~407 (2005)
29. Johnston-Wilson NL, "Disease-specific alterations in frontal cortex brain proteins in schizophrenia, bipolar disorder, and major depressive disorder. The Stanley Neuropathology Consortium", Mol Psychiatry, 5, pp.142~149 (2000)
30. Kapur S, "Antipsychotic dosing in preclinical models is often unrepresentative of the clinical condition: a suggested solution based on in vivo occupancy", J Pharmacol Exp Ther, 305, pp.625~631 (2003)
31. Towbin H, "Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications", Proc Natl Acad Sci U S A, 76, pp.4350~4354 (1979)
32. MacDonald ML, "Antipsychotic drugs elevate mRNA levels of presynaptic proteins in the frontal cortex of the rat", Biol Psychiatry, 57, pp.1041~1051 (2005)
33. Nakahara T, "Effect of chronic haloperidol treatment on synaptic protein mRNAs in the rat brain", Brain Res Mol Brain Res, 61, pp.238~242 (1998)
34. Castillo MA, "Deficits in syntaxin 1 phosphorylation in schizophrenia prefrontal cortex", Biol Psychiatry, 67, pp.208~216 (2010)
35. Cordeiro ML, "Lithium ions enhance cysteine string protein gene expression in vivo and in vitro", J Neurochem, 74, pp.2365~2372 (2000)
36. paroxetine binding protein and other rat brain proteins, "Psychopharmacology", 1992, 131~135
37. Vawter MP, "Reduction of synapsin in the hippocampus of patients with bipolar disorder and schizophrenia", Mol Psychiatry, 7, pp.571~578 (2002)
38. Zucker M, "Changes in vesicular monoamine transporter (VMAT2) and synaptophysin in rat Substantia nigra and prefrontal cortex induced by psychotropic drugs", Neuropsychobiology, 44, pp.187~191 (2001)
39. Eastwood SL, "Chronic haloperidol treatment differentially affects the expression of synaptic and neuronal plasticity-associated genes", Mol Psychiatry, 2, pp.322~329 (1997)
40. Sö~llner T, "SNAP receptors implicated in vesicle targeting and fusion", Nature, 362, pp.318~324 (1993)
41. Edelmann L, "Synaptobrevin binding to synaptophysin: a potential mechanism for controlling the exocytotic fusion machine", EMBO J, 14, pp.224~231 (1995)
42. Alder J, "Overexpression of synaptophysin enhances neurotransmitter secretion at Xenopus neuromuscular synapses", J Neurosci, 15, pp.511~519 (1995)
43. Clayton DF, "The synucleins: a family of proteins involved in synaptic function, plasticity, neurodegeneration and disease", Trends Neurosci, 21, pp.249~254 (1998)
44. Kaplan B, "Alpha-synuclein: its biological function and role in neurodegenerative diseases", J Mol Neurosci, 20, pp.83~92 (2003)
45. Liu S, "Alpha-Synuclein produces a long-lasting increase in neurotransmitter release", EMBO J, 23, pp.4506~4516 (2004)
46. BurréJ, "Alpha-synuclein promotes SNARE-complex assembly in vivo and in vitro", Science, 329, pp.1663~1667 (2010)
47. Abeliovich A, "Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system", Neuron, 25, pp.239~252 (2000)
48. Cabin DE, "Synaptic vesicle depletion correlates with attenuated synaptic responses to prolonged repetitive stimulation in mice lacking alpha-synuclein", J Neurosci, 22, pp.8797~8807 (2002)
49. Murphy DD, "Synucleins are developmentally expressed, and alpha-synuclein regulates the size of the presynaptic vesicular pool in primary hippocampal neurons", J Neurosci, 20, pp.3214~3220 (2000)
50. Frasca A, "Olanzapine, but not haloperidol, enhances PSA-NCAM immunoreactivity in rat prefrontal cortex", Int J Neuropsychopharmacol, 11, pp.591~595 (2008)
51. BüEttner B, "Cytoplasmic domain of NCAM 180 reduces NCAM-mediated neurite outgrowth", J Neurosci Res, 75, pp.854~860 (2004)
52. Dityatev A, "Synaptic strength as a function of post- versus presynaptic expression of the neural cell adhesion molecule NCAM", Neuron, 26, pp.207~217 (2000)
53. Polo-Parada L, "Distinct roles of different neural cell adhesion molecule (NCAM) isoforms in synaptic maturation revealed by analysis of NCAM 180 kDa isoform-deficient mice", J Neurosci, 24, pp.1852~1864 (2004)
54. Doherty P, "The neural cell adhesion molecule and synaptic plasticity", J Neurobiol, 26, pp.437~446 (1995)
55. Jeannotte AM, "Regulation of the norepinephrine transporter by alpha-synuclein-mediated interactions with microtubules", Eur J Neurosci, 26, pp.1509~1520 (2007)
56. Jeannotte AM, "Desipramine modulation of alpha-, gamma-synuclein, and the norepinephrine transporter in an animal model of depression", Neuropsychopharmacology, 34, pp.987~998 (2009)

관련 논문AI추천